Deal of the Day — limited-time pharmacy picks!
Renfor s 360mg Tablet

Renfor s 360mg Tablet

Prescription requiredRx Required

Salt Composition: Mycophenolate Sodium

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

10 Tablet(s) In A Strip

About The Product

ORGAN TRANSPLANT

Description

Renfor 360mg tablet is a prescription immunosuppressants medication. It is used with other combination of medication to prevent from rejecting an organ such as the kidney, liver and heart after a transplant.

It works by suppressing the body's immune system. It contains an active ingredient of Mycophenolate Sodium which belongs to the drug class of antimetabolite immunosuppressants (specifically, inosine monophosphate dehydrogenase [IMPDH] inhibitors).

Doctor's prescription is highly required while taking the medication as improper use or dose adjustment without medical supervision may increase the risk of serious infection. Follow the recommended dosage as advised by the healthcare professional.

Uses

  • Helps in organ transplant

Side Effects

  • Medication may show side effects some of them are resolve on their own while others require proper medication attention.
  • Renfor 360mg tablet also cause various side effects.
  • If the symptoms persist or worsen, consult the healthcare professional instantly.
  • Some of the symptoms include: • Diarrhea • Constipation • Loss of appetite • Shortness of breath • Weight loss • Increased heartbeat • Headache • Blood pressure problem • Anemia • Infections, fever, or sore throat • Unusual bleeding or bruising • Low blood cell count • Severe allergic reactions • Higher risk of developing lymphoma and other cancers • Nausea, abdominal pain​​

How To Use

  • Every medication has some dosage and duration that must be followed as directed by the healthcare supervision. Renfor 360mg tablet should be taken orally with or without food at the fixed time everyday.
  • Do not skip or miss the doses, take it regularly to get the most benefit and keep taking it even if the condition is well.​

How It Works

Renfor 360mg tablet contains Mycophenolate Sodium is converted into mycophenolic acid (MPA). It inhibits the enzyme inosine monophosphate dehydrogenase (IMPDH).

By blocking this pathway, the drug prevents T and B cells proliferation, reducing antibody production and immune response. In this way, it suppresses the immune system and prevents the rejection of transplanted organs.​

Safety Advice

Alcohol
Alcohol can increase the risk of side effects. It is best to avoid alcohol while using Renfor S 360mg tablet
Pregnancy
Renfor 360mg tablet can harm the unborn baby. Inform the doctor immediately when pregnancy occurs.
Breast Feeding
It is not for sure but Renfor 360mg tablet may pass into breast milk and could harm the baby in many ways. Stop breastfeeding while on this medication.
Driving
Driving is usually safe and does not cause any drowsiness while using Renfor 360mg tablet If the patient feels week, dizzy or unwell then avoid driving and operating machine.
Kidney
Regular kidney test and drug level monitoring are necessary as Renfor 360mg tablet can affect kidney function while transplanting.
Liver
Dose adjustment may be needed in people with liver disease when using Renfor 360mg tablet. Regular liver function test are usually required.

FAQs

Renfor tablet is an immunosuppressant medication containing (mycophenolic acid or mycophenolate sodium) which works by weakening the immune system to prevent the body from rejecting transplanted organs like kidney, heart or liver.

References

• Gabardi, S., Tran, J. L., & Clarkson, M.

R. (2003).

Enteric-coated mycophenolate sodium. Annals of Pharmacotherapy, 37(11), 1685-1693. https://pubmed.ncbi.nlm.nih.gov/14565799/ • Salvadori, M., Holzer, H., De Mattos, A., Sollinger, H., Arns, W., Oppenheimer, F., ... & Hall, M.

(2004). Enteric coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novorenal transplant patients.

American Journal of Transplantation, 4(2), 231-236. https://pubmed.ncbi.nlm.nih.gov/14974944/ • Budde, K., Glander, P., Diekmann, F., Waiser, J., Fritsche, L., Dragun, D., & Neumayer, H. H.

(2004). Review of the immunosuppressant enteric-coated mycophenolate sodium.

Expert opinion on pharmacotherapy, 5(6), 1333-1345. https://pubmed.ncbi.nlm.nih.gov/15163278/ • Behrend, M., & Braun, F. (2005).

Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil. Drugs, 65(8), 1037-1050. https://pubmed.ncbi.nlm.nih.gov/15907141/ • Budde, K., Bauer, S., Hambach, P., Hahn, U., Röblitz, H., Mai, I., ... & Glander, P.

(2007). Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients.

American journal of transplantation, 7(4), 888-898. https://pubmed.ncbi.nlm.nih.gov/17391132/​​​

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026